Keywords tumor immunology regulatory T cells master regulator analysis TRPS1 gemcitabine cancer systems biology Introduction To manifest as clinically apparent disease, cancer must evade a complex repertoire of host-protective immune-response mechanisms, the outcome of which is largely determined by the balance of inflammatory (anti-tumor) and tolerogenic (pro-tumor) immune cell function in the tumor microenvironment (TME).1 By contributing to a tolerogenic TME, the regulatory T cell (Treg)...
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Meri
Contact Meri, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack